ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Ticker Update

Updates

SUB-TYPE: COMPANY-LED RECALL

20.05.2015

Company-Led Drug Alert Ambre Solaire

Garnier is recalling the above products of Ambre Solaire to patient level due to a 'Label Misprint'.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batches
3135522Ambre sol clr prot spry f20 200mlGarnierAll Batches
3135548Ambre sol clr prot spry f30 200mlGarnierAll Batches
3432903Ambre sol lght&slk milk spf** 200mlGarnierAll Batches
3432879Ambre sol lght&slk milk spf30 200mlGarnierAll Batches
3681285Ambre sol milk spf30 50mlGarnierAll Batches
3263555Ambre solaire kids spray spf 50 200mlGarnierAll Batches
3135506Ambre sol clr prot spry** f10 200mlGarnierAll Batches
3429370Ambre sol kids rapido sprspf30 150mlGarnierAll Batches

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 3 RECALL

24.04.2015

Class 3 Drug Alert (action within 5 days) Exocin 3mg/ml Eye Drops (1 X 5ml)

Allergan UK Limited is recalling 'Danish Language Packs' of the above batch which have been shipped to the UK in error along with UK packs with the same batch number.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
0861989Exocin 3mg/ml Eye DropsAllergan LtdE75048
8076556PI Exocin 3mg/ml Eye DropsAllergan LtdE75048

For stock control enquiries please contact Allergan Customer Services Team on 0800 3767975
 

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

02.04.2015

Class 4 Drug Alert (Caution in use only) Epilim 200 & 500mg And Sodium Valproate

Sanofi UK have been made aware of an unusual odour associated with the above batches of Epilim / Sodium Valproate Gastro-resistant tablets. The odour has variously been described as ‘fishy', ‘sweaty armpits' and ‘cannabis'. An investigation by Sanofi has identified the root cause as the aluminium foil used in the packaging of affected batches. No impact on the quality or efficacy of the tablets has been detected. Sanofi has now ceased using this foil supplier.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batches

0269803Epilim Ec Tab 200mgSanofi UKJ601
J602
J603
K1
K2
K3
K7

0173534Epilim Ec Tab 500mgSanofi UKJ602
J603
K1
K2

Alliance do not stockSodium Val Tab 200mgZentivaK1

Alliance do not stockSodium Val Tab 500mgZentivaJ601

For all enquiries about this matter, please contact Sanofi Medical Information on 0845 3727101 or email UK-medicalinformation@sanofi.com 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

24.03.2015

Company-Led Drug Alert Vitaros 3mg/G X 4

Takeda UK Limited is recalling the below batch of Vitaros 3mg/G X 4 because this batch was distributed to the UK market in error between 3rd March and 11th March 2015..

Please visit the: GOV.UK website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
3845286Vitaros 3mg/G X 4Takeda UK Limited511742

For enquiries relating to stock return, please call your local Alliance Healthcare Limited Local Service Centre Customer Services Team.

For medical information enquiries, please contact Takeda on tel 01628 537900, email DSO-UK@takeda.com, fax 01628 526617.


Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

17.01.2015

Company-Led Drug Alert Rienso 30mg/ml solution for infusion

Takeda UK Limited is recalling the above batches because the patient information, carton and vial label have been updated to reflect the changed mode of administration from injection to infusion.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
Alliance Do Not StockRienso 30mg/ml solution for infusionTakeda UK Ltd240789
257893

Company contact for medical information enquiries:

Takeda UK Ltd
Tel: 01628 537900
Fax: 01628 526617
Email: DSO-UK@takeda.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

15.01.2015

Class 2 Drug Alert (action within 48 hours) Mitoxantrone 2mg/ml Concentrate for Solution for Infusio

Hospira UK Limited is recalling the above batches due to a number of confirmed out of specification test results obtained during stability studies. The out of specification results relate to both adverse impurity profile and low potency..

 

Please visit the: MHRA website for more details on this drug alert.

 

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
Alliance Do Not StockMitoxantrone 2mg/ml Concentrate for Solution for InfusionHospira UK LimitedZ054636AB

Alliance Healthcare do NOT stock and therefore we are not accepting stock returns.

For enquiries relating to stock return, please contact the Hospira UK Customer service team, tel: 0800 0287304; email: custserv@hospira.com

For medical information enquiries, please contact the Hospira medical information team, tel: 01926 83440; fax: 01926 834446; email: medinfouk@hospira.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

18.11.2014

Company-led drug alert Recivit Sublingual Tablets

Grunenthal Limited is recalling the affected batches below due to a manufacturing issue, there is a possibility that blisters from the above batches may contain missing and / or two tablets in a single blister cavity.

 

Please visit the: MHRA website for more details on this drug alert.

 

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
3830791Recivit 133mcg tabs x 30Grunenthal Limited14628
3830809Recivit 267mcg tabs x 30Grunenthal Limited14630
3830759Recivit 400mcg tabs x 30Grunenthal Limited14632
3830767Recivit 533mcg tabs x 30Grunenthal Limited15025
3830775Recivit 800mcg tabs x 30Grunenthal Limited14636

Please note that we have only identified 4 potential customers who have received these affected products from Alliance Healthcare and those customers will be contacted directly. The affected customers must ensure they have a AHDL "Returns Authorisation" code before attempting to hand the product(s) to the driver.

SUB-TYPE: CLASS 2 RECALL

13.11.2014

Class 2 Drug Alert (action within 48 hours) PI Zovirax Eye Ointment 4.50g

We have received a class 2 pharmacy level recall on PI ZOVIRAX OPHTHALMIC OINTMENT 4.50G which is being carried out for the same reason as the UK Zovirax Eye Ointment recall last week.

 

The: MHRA website is not available as yet.

 

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
7030877PI Zovirax Ophthalmic Oint 4.50gOPD/Sigma (The text on the actual box must be written in Spanish text)

Doncaster (The text on the actual box must be written in Spanish text)

Doncaster (The text on the actual box must be written in Italian text)
3M940


4C910


3M941

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

04.11.2014

Class 2 Drug Alert (action within 48 hours) Zovirax Eye Ointment

GlaxoSmithKline UK is recalling the above batches of Zovirax Eye Ointment as a precaution because the batches of pharmaceutical ingredient used in their manufacture were found to contain metal particles which were outside the upper specification limit for particle size.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
0455329Zovirax Ophthalmic Ointment 4.50gGlaxosmithkline UK Ltd3L942
3M941

For medical information enquiries please contact GlaxoSmithKline Medical Information, tel: 0800 221 441 email: ukmedinfo@gsk.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

08.10.2014

Company-led drug recall Phenobarbital 50mg/5ml

Nupharm Laboratories is recalling the above batches due to the reported crystallisation of the product over time..

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
Alliance do not stockPhenobarbital 50mg/5ml, 200ml bottleNupharm LaboratoriesDB1121A
Alliance do not stockPhenobarbital 50mg/5ml, 200ml bottleNupharm LaboratoriesDB1121B
Alliance do not stockPhenobarbital 50mg/5ml, 200ml bottleNupharm LaboratoriesDB1121C
Alliance do not stockPhenobarbital 50mg/5ml, 200ml bottleNupharm LaboratoriesDE2511A
Alliance do not stockPhenobarbital 50mg/5ml, 200ml bottleNupharm LaboratoriesDE2581A
Alliance do not stockPhenobarbital 50mg/5ml, 200ml bottleNupharm LaboratoriesDE2661A
Alliance do not stockPhenobarbital 50mg/5ml, 200ml bottleNupharm LaboratoriesDE2691A
Alliance do not stockPhenobarbital 50mg/5ml, 200ml bottleNupharm LaboratoriesDE2691B
Alliance do not stockPhenobarbital 50mg/5ml, 200ml bottleNupharm LaboratoriesDG3371A
Alliance do not stockPhenobarbital 50mg/5ml, 100ml bottleNupharm LaboratoriesDB1122A

Alliance Healthcare do not stock this product and are therefore not accepting stock returns.

 

Company contact for stock enquiries: Anne O'Grady, Head of Quality on Tel: 01244 287940 or Mobile: 07713 939118.

 

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.